JY
NVOS

Jeff Yass’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Jeff Yass’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,853
Closed -$8.7K – 13605
2024
Q1 		$8.7K Buy
+17,853
New +$12K ﹤0.01% 11921

Other funds holding NVOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jeff Yass's NVOS Position: Q2 2024 in Review

Jeff Yass sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q2 2024, closing a stake of 17,853 shares — an estimated $8.7K sold.

Jeff Yass first reported a position in NVOS in Q1 2024 and held it in 1 quarter. The position peaked at $8.7K in Q1 2024. 16 funds tracked by Wall St. Rank hold NVOS as of Q2 2024.

  • Jeff Yass reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jeff Yass sold 17,853 Novo Integrated Sciences, Inc. Common Stock shares in Q2 2024, an estimated $8.7K.
  • Jeff Yass first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • Jeff Yass's Novo Integrated Sciences, Inc. Common Stock position peaked at $8.7K in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.